STOCKS TELEGRAPH

Tag: Iterum stock

  • Iterum Therapeutics plc (ITRM) stock drops in Pre-Market today : Here’s to know why

    Shares of the Iterum Therapeutics plc (ITRM) stock were dropping in the pre-market trading session today on July 28, 2021, after rising to a good height in the last trade. ITRM stock price saw a decline of 6.88% to drop at $0.69 a share at the time of this writing. The penny stock went high by 17.53% at the previous closing. Let’s try to figure out the reason behind this fall.

    What’s Happening?

    Iterum Therapeutics plc is the clinical-stage biotechnology stock that develops anti-infectives to treat infectious diseases that cause due to multi-drug resistant pathogens.  ITRM stock is falling in pre-market today despite any obvious reason related to it. No specific news or announcement in today’s date is available to justify the bearish sentiment. ITRM stock dropped 68.73% in the last 30 days and in the past 12 months, the penny stock dropped by 32.64%. Let’s take a look at some recent events of the Iterum.

    ITRM stock received Response Letter from FDA:

    Iterum stock received a complete response letter(CRL) from U.S Food and Drug Administration for its new drug application(NDA) oral sulopenem on July 23, 2021. The FDA did not approve the new drug application in its present form. According to CRL, FDA acknowledged the significant statistical data of the overall response rate of the oral sulopenem against ciprofloxacin in the population resistant to ciprofloxacin. However, FDA mentioned in the CRL that this data is not sufficient and demanded additional data for the approval of the drug.

    FDA recommendations to ITRM stock:

    The FDA recommended Iterum stock to conduct at least one more well-controlled and adequate clinical trial by using a different comparator drug. Moreover, the recommendations also included a nonclinical investigation of the NDA in order to determine the optimal dose prescription. However, this recommendation was not connected with approvability of the drug.

    Financial View of ITRM stock:

    According to the first quarter 2021 financial results, Iterum stock suffered a net loss of  $98.9 million as compared to a $16.1 million net loss in the same quarter of the prior year. The penny stock spent $2.5 million and $3.4 million in R&D expenses and general and administrative expenses respectively. At the end of the first quarter, Iterum had $100.5 million in cash, cash equivalents, and short-term investments.

    Wrap Up:

    The penny stock is now red in Wednesday’s pre-market trading session after a strong gain in the last trade. ITRM stock has a market cap of 132.7 million and a 13,786,501 average trading volume.

  • Is This Why The Iterum Therapeutics (ITRM) Stock Fell Pre-Hours Today?

    Iterum Therapeutics plc (ITRM) fell -43.37% to $0.64 at the last check in premarket trading sessions on Monday. To complete the last trading session, ITRM stock declined by -2.59% to $1.13. There was a price range between $1.0761 and $1.17 for Iterum shares. On average, ITRM traded 13.67 million shares daily over the last 100 days, which was above its volume of 12.07 million shares traded on the day.

    Over the last five days, ITRM shares have lost -2.59 percent, while they have lost -43.78% over the last month. Since the ITRM stock is falling in absence of any current news, we can draw our attention to recent developments to gain a better understanding of ITRM.

    Have things been going well at Iterum Therapeutics lately?

    Known for developing differentiated anti-infectives aimed at combating the global challenge of multi-drug resistant pathogens, ITRM stock mission is to significantly improve the health and wellbeing of patients suffering from life-threatening diseases around the globe. ITRM is in Phase 3 clinical development of sulopenem, a drug compound for anti-infective agents that is derived from penems, with an oral and IV formulation. Various gram-negative, gram-positive, and anaerobic bacteria resistant to other antibiotics have shown potent in vitro activity against sulopenem.

    A letter was recently received by Iterum from the US Food and Drug Administration (“FDA”).

    • As part of its ongoing review of ITRM stock New Drug Application (NDA), the FDA noted deficiencies that prevent the continuation of discussions about labeling and post-marketing requirements while the assessment of the NDA is ongoing.
    • FDA’s notification did not contain any information concerning deficiencies.
    • Additionally, the letter states a decision has not yet been made regarding the information being reviewed.
    • In a letter dated January 21, 2021, the FDA assigned a target date of July 25 for the completion of its review of the NDA under the Prescription Drug User Fee Act (“PDUFA”).
    • ITRMS aims to work with the FDA to understand the specific issues and resolve them quickly.

    How ITRM will be rectifying the deficiencies?

    Despite being disappointed by this news, ITRM stock management remains confident in sulopenem’s ability to help address the growing problem of antibiotic resistance. As a result, ITRM set out to work with the FDA to identify and resolve the issues efficiently to encourage its continued advancement.

    Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant pathogens to significantly improve the lives of people affected by serious and life-threatening diseases around the world. ITRM stock is advancing its first compound, sulopenem, a novel penem anti-infective compound, in Phase 3 clinical development with an oral formulation and IV formulation. Sulopenem has demonstrated potent in vitro activity against a wide variety of gram-negative, gram-positive, and anaerobic bacteria resistant to other antibiotics. Iterum Therapeutics has received Qualified Infectious Disease Product (QIDP) and Fast Track designations for its oral and IV formulations of sulopenem in seven indications. The NDA for sulopenem etzadroxil/probenecid for the treatment of uncomplicated urinary tract infections in patients with a quinolone non-susceptible pathogen has been accepted for review by the FDA and a PDUFA goal date of July 25, 2021, has been assigned to it.

  • Early Morning Vibes: 4 Trending Stocks To Watch Right Now

    Early Morning Vibes: 4 Trending Stocks To Watch Right Now

    On February 12, American stock markets closed in the green. The S&P 500 Index climbed 0.47% to 3935 points, the NASDAQ rose 0.50%, and the Dow Jones added a symbolic 0.09%. Prospects for the adoption of another fiscal stimulus program in the States continued to support quotations. The healthcare sector outperformed the market, climbing 0.75% on a positive Illumina report. The finance sector grew 0.95% on the back of rising Treasury yields.

    Company news

    Illumina (ILMN: + 11.9%) quarterly results exceeded expectations on strong demand for DNA instruments.

    PayPal (PYPL: + 4.7%) expects to double the number of users of the payment system by 2025 from its current 377 million, tripling the volume of transactions.

    HubSpot (HUBS: + 16.4%), a cloud-based marketing and sales solutions provider, delivered strong reporting on the digitalization trend in small and medium-sized businesses.

    Today, global stock markets are showing mixed dynamics. The news background remains quite calm. Market participants’ optimism is boosted by the improved epidemiological situation in Europe and the USA, accelerated vaccination, and the prospects for fiscal stimulus. The seven-day average number of coronavirus cases in the United States for the first time since November fell below 100 thousand, and the number of hospitalized people fell from 80 thousand to 65 thousand in just a week. The situation is improving in all 50 states. Pessimists expect new outbreaks of disease due to the spread of virus mutations, however, if the current positive trends continue, the anticoid restrictions will begin to be lifted everywhere pretty soon.

    Joe Biden plans to make his first trip outside Washington as president today. He will deliver a speech in Wisconsin on the fiscal stimulus package. The president is also expected to speak out on the pandemic and its impact on the US economy. The purpose of the speech is ultimately to speed up the negotiating process in Congress. No new information is expected, but the broadcast of the president’s speech may have a positive effect on the sentiment of private investors, whose share in trade turnover continues to increase.

    The Freedom Finance Sentiment Index climbed to 71 out of 100. The indicator reflects market participants’ hope for a global economic recovery in 2021. Worries about the negative impact of the coronavirus pandemic continue to ease thanks to the prospect of mass vaccinations.

    Technically, the S&P 500 remains in an uptrend. Resistance at its upper boundary is still a significant obstacle. A breakthrough of this resistance at 3950 points will mean an acceleration of growth. However, the RSI indicator is already close to the overbought level, so the positive potential in the short-term is limited.

    Today Top Movers

    Strongbridge Biopharma plc (SBBP) share price jumped 53.01% to $5.08 during the early morning ‎trading session on ‎Tuesday.‎ 

    ‎Socket Mobile Inc (SCKT), a Computer Hardware company, soared about 72.44% ‎at $5.59 in pre-market ‎trading Tuesday after the company launched the first enterprise-grade scanners for Apple iPhone 12 series. 

    ‎Denison Mines Corp (DNN) stock ascended 17.11% at $1.30 in the pre-market trading today.‎‎ 

    ‎Sundial Growers Inc (SNDL) gained over 9.13% at $2.27 in pre-market ‎trading on Tuesday.‎‎

    Top Upgrades & Downgrades

    Wells Fargo turned bullish on Extraction Oil & Gas Inc. (XOG), upgrading the stock to “Overweight” and assigning a $38.0 price target, representing a potential upside of 19.5% from Friday’s close. 

    Anaplan Inc. (PLAN) has won the favor of Morgan Stanley’s equity research team. The firm upgraded the shares from Equal-Weight to Overweight and moved their price target to $100.0, suggesting a 21.49% additional upside for the stock. 

    Albemarle Corporation (ALB) received an upgrade from analysts at Deutsche Bank, who also set their one-year price target on the stock to $190.0. They changed their rating on ALB to Buy from Hold in a recently issued research note. 

    Earlier Sunday Baird reduced its rating on American Express Company (AXP) stock to Neutral from Outperform and assigned the price target to $126. 

    Baird analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for Republic Services Inc. (RSG) has been changed to Neutral from Outperform and the new price target is set at $96. 

    Analysts at Baird downgraded Waste Management Inc. (WM)’s stock to Neutral from Outperform Tuesday.

    Latest Insider Activity

    Iterum Therapeutics plc (ITRM) 10% Owner DENNER ALEXANDER J announced the sale of shares taking place on Feb 12 at $2.27 for some 10,619,949 shares. The total came to more than $24.11 million. 

    Uber Technologies Inc. (UBER) Hazelbaker Jill sold on Feb 12 a total of 126,953 shares at $60.12 on average. The insider’s sale generated proceeds of almost $1.25 million. 

    InspireMD Inc. (NSPR) Director Kester Thomas J declared the purchase of shares taking place on Feb 08 at $0.62 for some 120,960 shares. The transaction amount was around $74995. 

    Dun & Bradstreet Holdings Inc. (DNB) Chief Financial Officer Hipsher Bryan T. bought on Feb 11 a total 9,000 shares at $23.30 on average. The purchase cost the insider an estimated $116,500.

    Important Earnings

    Top US earnings releases scheduled for today include Sabre Corporation (NASDAQ: SABR). It will announce its Dec 2020 financial results. The company is expected to report earnings of -$0.66 per share from revenues of $328.57M in the three-month period. 

    Analysts expect Genworth Financial Inc. (NYSE: GNW) to report a net income (adjusted) of $0.22 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $2.06B. 

    Occidental Petroleum Corporation (OXY), due to announce earnings after the market closes today, is expected to report earnings of -$0.58 per share from revenues of $4.37B recently concluded three-month period.

  • Early Morning Vibes: Top 4 Stocks To Buy Right Now

    Early Morning Vibes: Top 4 Stocks To Buy Right Now

    The session on February 8, American stock markets ended in the green zone. The S&P 500 index rose 0.74% to 3916 points, the Dow Jones rose 0.76% and the NASDAQ surged 0.57%. All three indices renewed their all-time highs. The growing prospects for a major economic support package in the US remain in focus. The energy sector climbed 4.17% on the back of an ongoing rally in oil. Increased risk appetite triggered a 0.78% correction in the defensive utility sector.

    Company news

    Children’s goods maker Hasbro (HAS: -4.3%) beat expectations, but management noted weak holiday sales.

    Palantir (PLTR: + 5.9%) announced a partnership with IBM (IBM: + 1.5%) to develop technology products.

    Tesla (TSLA: + 1.3%) invested $ 1.5 billion in bitcoin and announced that it will accept cryptocurrency as payment for electric cars.

    Today, global stock markets are showing mixed dynamics. Discussions on the fiscal stimulus package remain in the spotlight. The passage of a bill on public spending in the amount of about $ 1.9 trillion threatens to accelerate inflation. Some experts warn about this, in particular, former Treasury Secretary Larry Summers. Investors in the debt market are reacting to this risk, so the day before, the rate on 30-year Treasuries rose above 2% for the first time in a year. Rising bond rates could put pressure on the attractiveness of the stock market, primarily on growth stocks, of which tech companies are prime examples.

    The epidemiological situation in the United States continues to improve rapidly, despite the circulation of new strains of coronavirus. The number of hospitalized people dropped to 80 thousand, more than 10% of Americans have already received the first dose of the vaccine. However, the risk of another jump in the incidence remains, so the CDC is not yet recommending state authorities to remove the antiquated restrictions.

    Technical picture

    Technically, the S&P 500 is still in a medium-term uptrend. The session ended the day before at the upper trend line, which is still a significant obstacle. The S & P500 index recorded growth for the sixth session in a row, so short-term consolidation is likely.

    Today Top Movers

    Iterum Therapeutics PLC (ITRM) stock ascended 61.69% at $2.04 in the pre-market trading today.‎‎ Ra Capital Management reportedly disclosed ownership of 13,730,376 shares of Iterum Therapeutics plc by filing a 13G form with the Securities and Exchange Commission. 

    ‎Assertio Therapeutics Inc (ASRT) gained over 25.24% at $1.29 in pre-market ‎trading on Tuesday.‎‎ Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital and pain and inflammation. 

    ‎Aurora Mobile Ltd (JG) grew over 13.91% at $6.55 in pre-market trading ‎today following the receipt of the InfoQ 2020 Best Technology Community Award at the Developer Ecosystem Co-creation Program virtual conference, hosted by InfoQ.‎

    ‎Marathon Patent Group Inc (MARA) stock moved up 16.93 percent to $37.50 in the pre-market ‎trading.‎‎ MARA stock is rallying because of the spike in Bitcoin. Marathon Patent Group bills itself as one of the largest Bitcoin self-mining companies.

    Top Upgrades & Downgrades

    JP Morgan turned bullish on KKR Real Estate Finance Trust Inc. (KREF), upgrading the stock to “Overweight”.

    Twilio Inc. (TWLO) has won the favor of JP Morgan’s equity research team. The firm upgraded the shares from Neutral to Overweight and moved their price target to $465.0, suggesting a 1.39% additional upside for the stock. 

    The Community Financial Corporation (TCFC) received an upgrade from analysts at Piper Sandler, who also set their one-year price target on the stock to $34.0. They changed their rating on TCFC to Overweight from Neutral in a recently issued research note. 

    Earlier Tuesday JP Morgan reduced its rating on Ladder Capital Corp (LADR) stock to Underweight from Neutral and assigned the price target to $10. 

    Needham analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Cubic Corporation (CUB) has been changed to Hold from Buy.

    Latest Insider Activity

    Advanced Micro Devices Inc. (AMD) EVP, Computing & Graphics Bergman Rick announced the sale of shares taking place on Feb 04 at $88.29 for some 2,000 shares. The total came to more than $0.18 million. 

    Facebook Inc. (FB) COB and CEO Zuckerberg Mark sold on Feb 05 a total of 44,750 shares at $267.92 on average. The insider’s sale generated proceeds of almost $11.99 million. 

    Accuray Incorporated (ARAY) Director WHITTERS JOSEPH E declared the purchase of shares taking place on Feb 01 at $5.02 for some 20,000 shares. The transaction amount was around $0.1 million. 

    Consolidated Edison Inc. (ED) President & CEO CET Nachmias Stuart bought on Jan 31 a total 1,078 shares at $70.78 on average. The purchase cost the insider an estimated $667.

    Important Earnings

    Top US earnings releases scheduled for today include Cisco Systems Inc. (NASDAQ: CSCO). It will announce its Jan 2021 financial results. The company is expected to report earnings of $0.76 per share from revenues of $11.92B in the three-month period. 

    Analysts expect Isoray Inc. (AMEX: ISR) to report a net income (adjusted) of -$0.01 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $2.39M. 

    Twitter Inc. (TWTR), due to announce earnings after the market closes today, is expected to report earnings of $0.31 per share from revenues of $1.19B recently concluded three-month period.

  • 21 Stocks Taking Bigger Strides in Pre Market Session

    21 Stocks Taking Bigger Strides in Pre Market Session

    ‎Velodyne Lidar Inc. (VLDR) stock soared 7.5% to $26.53 in the pre-market trading ‎after reporting that it has joined the Qualcomm® Smart Cities Accelerator Program to promote using ‎lidar technology in smart city solutions. The most recent rating by Needham, on December 15, 2020, is ‎a Buy. ‎

    ‎MicroVision Inc. (MVIS) grew over 14.38% at $6.6 in pre-market trading today.‎

    ‎Aurora Mobile Limited (NASDAQ: JG) shares are trading up 48.9% at $4.75 at the ‎time of writing following the announcement from the firm that it has entered into a partnership ‎agreement with a global leading new energy vehicle manufacturer. Company’s 52-week ranged ‎between $1.40 to $5.43.‎

    ‎Castor Maritime Inc. (CTRM) stock moved down -3.97 percent to $0.1522 in the pre-‎‎‎‎market trading.‎

    ‎HEXO Corp. (HEXO), a Drug Manufacturers – Specialty & Generic company, rose ‎about 8.0% at $1.08 in pre-market trading Tuesday after reporting lapse of base shelf prospectus.‎

    ‎Novan Inc. (NOVN) stock plunged -5.8% to $0.6396 in the pre-market trading after ‎declaring that it has entered into a Master Services Agreement (MSA) with Catalent.‎

    ‎Nano Dimension Ltd. (NNDM) gained over 2.38% at $8.61 in pre-‎‎‎market ‎trading ‎Tuesday December 22, 2020.‎

    ‎Gevo Inc. (NASDAQ: GEVO) shares are trading up 8.39% at $3.1 at the time of ‎writing following the declaration from the company that it has optioned the right to purchase ‎approximately 239 acres of land near Lake Preston, SD Company’s 52-week ranged between $0.46 to ‎‎$2.87. Gevo Options Site for Expansion Project.‎

    ‎electroCore Inc. (ECOR) gained over 7.36% at $1.75 in pre-market trading Tuesday ‎December 22, 2020 after reporting agreement with Pro Medical Baltic to be exclusive distributor for ‎gammaCore Sapphire in Eastern Europe.‎

    ‎Nxt-ID Inc. (NXTD), a Security & Protection Services company, dropped about -‎‎‎‎4.41% at $1.3 in pre-market trading Tuesday.‎

    ‎Iterum Therapeutics plc (NASDAQ: ITRM) shares are trading up 2.35% at $1.0 at the ‎time of writing after receiving approval to transfer to Nasdaq Capital Market. Company’s 52-week ‎ranged between $0.45 to $6.47. Analysts have a consensus price target of $2. ‎

    ‎Aurora Cannabis Inc. (ACB) stock moved up 2.13 percent to $9.13 in the pre-‎‎‎market ‎trading.‎

    ‎Venus Concept Inc. (VERO) tumbled over -16.14% at $2.13 in pre-market trading ‎today following the announcement of proposed public offering.‎

    ‎UP Fintech Holding Limited (NASDAQ: TIGR) shares are trading up ‎‎7.97% ‎at ‎‎$6.37 ‎at ‎the time of writing. Company’s 52-week ranged between $2.03 to $7.60.‎

    ‎IZEA Worldwide Inc. (IZEA) lost over -1.78% at $1.38 in pre-‎‎market ‎trading ‎Tuesday ‎December 22, 2020.‎

    ‎500.com Limited (WBAI), a Gambling company, rose about 9.14% at $4.18 in pre-‎market trading Tuesday following the declaration from the firm that it has entered into a definitive ‎share subscription agreement with Good Luck Information Technology Co., Limited , a company ‎incorporated in Hong Kong, for the issuance and sale of newly issued Class A ordinary shares of the ‎Company.‎

    ‎Liminal BioSciences Inc. (LMNL) stock soared 2.76% to $5.21 in the pre-‎‎‎market ‎trading. The most recent rating by Piper Sandler, on December 21, 2020, is an Overweight.‎

    ‎Palantir Technologies Inc. (PLTR) gained over 1.72% at $29.0 in pre-market trading ‎Tuesday December 22, 2020 after declaring that the U.S. Army’s Program Executive Office for ‎Enterprise Information Systems (PEO EIS) opted to execute the second year of its partnership with ‎Palantir on the Army Vantage program, for a total price of $113.8 million for the year.‎

    ‎EyeGate Pharmaceuticals Inc. (EYEG) is down more than -3.84% at $5.01 in pre-‎market hours Tuesday December 22, 2020 after announcing the acquisition of Panoptes Pharma. The ‎stock had jumped over 45.94% to $5.21 in the last trading session. ‎

    Before the trading started on December 22, 2020, Kopin Corporation (KOPN) ‎is ‎up ‎‎8.43% to reach $2.83. It has been trading in a 52-week range of $0.19 to $2.16.‎

    ‎Bit Digital Inc. (BTBT) grew over 4.96% at $6.56 in pre-market trading today following ‎the release of its third quarter of fiscal year 2020 financial results.‎

  • What changed for these 49 stocks in Pre Market Session

    What changed for these 49 stocks in Pre Market Session

    Lizhi Inc. (LIZI) stock plunged -8.14% to $4.4 in the pre-market trading after reporting that it entered in-car audio collaboration with Xpeng Motors. The most recent rating by Citigroup, on February 18, 2020, is a Buy.
    American Airlines Group Inc. (NASDAQ: AAL) shares are trading up 4.72% at $16.85 at the time of writing. Company’s 52-week ranged between $8.25 to $30.78.
    FuelCell Energy Inc. (FCEL) is up more than 5.01% at $7.75 in pre-market hours Friday December 04, 2020. The firm recently declared the pricing of its underwritten public offering of 34,518,539 shares of its common stock, at a public offering price of $6.50 per share. The stock had jumped over 1.93% to $7.38 in the last trading session.
    Before the trading started on December 04, 2020, AMC Entertainment Holdings Inc. (AMC) is up 5.51% to reach $3.83. It has been trading in a 52-week range of $1.95 to $8.78.
    Cinemark Holdings Inc. (CNK) stock soared 6.02% to $14.1 in the pre-market trading. The most recent rating by Loop Capital, on November 19, 2020, is a Hold.
    Iterum Therapeutics plc (ITRM), a Biotechnology company, dropped about -3.8% at $0.809 in pre-market trading Friday.
    Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) shares are trading up 3.7% at $26.36 at the time of writing following its announcement extension of suspension of voyages. Company’s 52-week ranged between $7.03 to $59.78. Analysts have a consensus price target of $26.
    Before the trading started on December 04, 2020, Jaguar Health Inc. (JAGX) is up 7.84% to reach $0.399. It has been trading in a 52-week range of $0.19 to $1.08.
    Transocean Ltd. (RIG), a Oil & Gas Drilling company, rose about 4.43% at $2.12 in pre-market trading Friday after declaring amendments to certain financing documents and internal reorganization transactions to resolve allegations contained in purported notices of default.
    Novan Inc. (NOVN) stock soared 19.92% to $0.67 in the pre-market trading. The most recent rating by Piper Jaffray, on January 06, 2020, is a Neutral.
    Li Auto Inc. (LI) lost over -2.48% at $31.51 in pre-market trading Friday December 04, 2020 following declaration its pricing of follow-on public offering of American depositary shares.
    Southwestern Energy Company (NYSE: SWN) shares are trading up 2.13% at $2.88 at the time of writing. Company’s 52-week ranged between $1.06 to $3.90. Analysts have a consensus price target of $2.40.
    Occidental Petroleum (OXY) is up more than 3.23% at $16.92 in pre-market hours Friday December 04, 2020. The company recently reported the release of its 2020 Climate Report, which provides a pathway detailing milestones to achieve its net-zero aspirations. The stock had jumped over 3.15% to $16.39 in the last trading session.
    Torchlight Energy Resources Inc. (TRCH) is up more than 6.9% at $0.48 in pre-market hours Friday December 04, 2020. The stock had jumped over 15.13% to $0.45 in the last trading session.
    TransGlobe Energy (TGA) grew over 2.82% at $0.659 in pre-market trading today following its agreement to merge, extend and modernize its eastern Desert concessions.
    Before the trading started on December 04, 2020, Catabasis Pharmaceuticals Inc. (CATB) is up 2.07% to reach $1.97. It has been trading in a 52-week range of $1.25 to $8.59.
    Inovio Pharmaceuticals Inc. (INO) stock moved up 8.07 percent to $13.53 in the pre-market trading after declaring the execution of an agreement with Kaneka Eurogentec S.A., for Eurogentec to manufacture INOVIO’s COVID-19 vaccine candidate INO-4800 at their industry-leading GMP plasmid production scales.
    Clovis Oncology Inc. (CLVS) is down more than -4.81% at $5.15 in pre-market hours Friday December 04, 2020. The stock had jumped over 11.09% to $5.41 in the last trading session.
    Cinedigm Corp. (CIDM) gained over 71.43% at $0.96 in pre-market trading Friday December 04, 2020 after reporting that its eight additional linear streaming channels are now Available on Rad’s fast-growing global streaming platform.
    Onconova Therapeutics Inc. (ONTX) stock plunged -1.9% to $0.3143 in the pre-market trading. The most recent rating by H.C. Wainwright, on March 01, 2018, is a Buy.
    Marvell Technology Group Ltd. (MRVL) stock plunged -5.1% to $43.2 in the pre-market trading after announcing a quarterly dividend of $0.06 per share of common stock payable on January 14, 2021 to shareholders of record as of December 23, 2020. The most recent rating by Craig Hallum, on October 30, 2020, is a Buy.
    QEP Resources Inc. (QEP) stock soared 5.0% to $2.1 in the pre-market trading. The most recent rating by JP Morgan, on July 20, 2020, is a Neutral.
    Arlo Technologies Inc. (NYSE: ARLO) shares are trading up 3.09% at $7.0 at the time of writing. The company recently revealed that Matthew McRae, CEO, and Gordon Mattingly, CFO, will present at the Raymond James Virtual Technology Investors Conference on Tuesday, December 8, 2020. Company’s 52-week ranged between $1.20 to $7.75. Analysts have a consensus price target of $6.
    Before the trading started on December 04, 2020, Nxt-ID Inc. (NXTD) is down -3.91% to reach $0.41. It has been trading in a 52-week range of $0.21 to $0.89.
    Halliburton Company (HAL) gained over 3.66% at $18.68 in pre-market trading Friday December 04, 2020 following its deal with Accenture (ACN), to accelerate Halliburton’s digital supply chain transformation and support digitalization within the Company’s manufacturing function.
    United Microelectronics (UMC) stock soared 10.32% to $8.55 in the pre-market trading. The most recent rating by Credit Suisse, on October 12, 2020, is an Outperform.
    Before the trading started on December 04, 2020, Cloudera Inc. (CLDR) is up 14.85% to reach $13.3 after reporting results for its third quarter of fiscal 2021, ended October 31, 2020. It has been trading in a 52-week range of $4.76 to $14.20.
    Before the trading started on December 04, 2020, Isoray Inc. (ISR) is down -4.92% to reach $0.47. It has been trading in a 52-week range of $0.35 to $1.06.
    iBio Inc. (AMEX: IBIO) shares are trading down -0.66% at $1.51 at the time of writing. The firm recently reported an agreement with Belgium-based ATB Therapeutics to produce its bioengineered antibody-toxin fusion proteins using iBio’s FastPharming® System. Company’s 52-week ranged between $0.14 to $7.45. Analysts have a consensus price target of $2.55.
    Centennial Resource Development Inc. (CDEV) stock soared 3.13% to $1.32 in the pre-market trading. The most recent rating by MKM Partners, on November 30, 2020, is a Neutral.
    BioCryst Pharmaceuticals Inc. (BCRX) is up more than 24.44% at $6.39 in pre-market hours Friday December 04, 2020 following the FDA Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to prevent attacks in Hereditary Angioedema patients. The stock had jumped over 1.88% to $5.14 in the last trading session.
    Borr Drilling Limited (BORR) is up more than 6.86% at $0.854 in pre-market hours Friday December 04, 2020. The stock had dropped over -1.78% to $0.80 in the last trading session.
    Before the trading started on December 04, 2020, Blink Charging Co. (BLNK) is up 4.14% to reach $23.64 after declaring an agreement with JSC Management Group, a large Burger King franchisee, to deploy numerous EV charging stations at key Burger King locations across the Northeast. It has been trading in a 52-week range of $1.25 to $34.67.
    Banco Santander S.A. (SAN) grew over 3.74% at $3.33 in pre-market trading today.
    Kandi Technologies Group Inc. (NASDAQ: KNDI) shares are trading up 2.98% at $8.3 at the time of writing. Company’s 52-week ranged between $2.17 to $17.45.
    InVivo Therapeutics Holdings Corp. (NVIV) lost over -4.67% at $0.6101 in pre-market trading Friday December 04, 2020.
    Aehr Test Systems (AEHR), a Semiconductor Equipment & Materials company, dropped about -8.74% at $1.88 in pre-market trading Friday after receiving $4.3 million order for initial FOX-XP™ test cell for production test of mobile sensor devices.
    ICICI Bank Limited (IBN) grew over 4.48% at $13.75 in pre-market trading today.
    NanoVibronix Inc. (NAOV) stock moved down -7.96 percent to $1.04 in the pre-market trading following the announcement of $6.0 million private placement.
    DocuSign Inc. (DOCU), a Software – Application company, rose about 4.43% at $241.25 in pre-market trading Friday.
    Dada Nexus Limited (DADA) is up more than 4.4% at $47.2 in pre-market hours Friday December 04, 2020 after reporting that Dada Now has partnered with dozens of cake chain brands across China, doubling the number of cooperating stores year-over-year as of November 2020. The stock had dropped over -15.65% to $45.21 in the last trading session.
    Salarius Pharmaceuticals Inc. (SLRX) stock moved up 1.85 percent to $1.1 in the pre-market trading.
    Auris Medical Holding Ltd. (NASDAQ: EARS) shares are trading down -3.23% at $3.3 at the time of writing after it pricing $8,000,000 common shares offering priced at-the-market. Company’s 52-week ranged between $0.65 to $6.60. Analysts have a consensus price target of $2.50.
    Acasti Pharma Inc. (ACST) lost over -2.94% at $0.33 in pre-market trading Friday December 04, 2020.
    Micro Focus International plc (MFGP) is up more than 6.3% at $6.07 in pre-market hours Friday December 04, 2020. The firm recently declared the findings of its ‘Endless Modernization’ research with Standish Group. The stock had jumped over 14.66% to $5.71 in the last trading session.
    BP p.l.c. (BP), a Oil & Gas Integrated company, rose about 4.54% at $22.33 in pre-market trading Friday.
    Tantech Holdings Ltd (NASDAQ: TANH) shares are trading up 4.27% at $1.71 at the time of writing after announcing the launch by its subsidiary, Shangchi Automobile Co., Ltd. (“Shangchi Automobile”), of its newest highly innovative driverless and autonomous street sweeper. Company’s 52-week ranged between $0.81 to $3.65.
    Trine Acquisition Corp. (TRNE) gained over 7.05% at $15.49 in pre-market trading Friday December 04, 2020.
    Enlivex Therapeutics Ltd. (ENLV) grew over 5.26% at $12.0 in pre-market trading today after reporting positive interim results of an investigator-initiated Phase II clinical trial evaluating AllocetraTM in severe and critical COVID-19 patients.